New Antiviral Drug GHP-88310 Shows Promise in Blocking Measles-Like Virus Transmission
Researchers at Georgia State University have developed an oral antiviral drug, GHP-88310, which has shown effectiveness in preventing the transmission of a measles-like virus in ferrets. The study, published in Nature Microbiology, demonstrated that the drug blocked both direct contact and airborne transmission of the virus, significantly reducing clinical symptoms. The drug, a broad-spectrum orthoparamyxovirus polymerase inhibitor, was administered prophylactically and therapeutically, showing potential to augment traditional vaccination methods. The research aims to address the resurgence of measles cases in the U.S., attributed to declining vaccination rates.